Phase 1 Randomized, Double-Blind, Placebo-Controlled, Single Ascending-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DB-020 in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 20 May 2019
Price : $35 *
At a glance
- Drugs DB 020 (Primary) ; Hyaluronic acid
- Indications Sensorineural hearing loss
- Focus Adverse reactions
- Sponsors Decibel Therapeutics
- 17 May 2019 Status changed from not yet recruiting to completed.
- 01 Nov 2018 Planned initiation date changed from 18 Oct 2018 to 2 Nov 2018.
- 24 Oct 2018 New trial record